
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Alan L. Ho discloses the following relationships and financial interests:
-
Affyimmune Therapeutics, Inc.
Professional Services and Activities -
Chemotherapy Foundation Symposium
Professional Services and Activities -
Chinese American Hematology and Oncology Network
Professional Services and Activities -
Elevar Therapeutics
Professional Services and Activities -
Endocrine Society
Professional Services and Activities -
Exelixis
Professional Services and Activities -
ExpertConnect
Professional Services and Activities -
Kura Oncology
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities
-
National Cancer Institute
Professional Services and Activities -
National Institutes of Health (NIH)
Professional Services and Activities -
New York University (NYU)
Professional Services and Activities -
Northwestern University
Professional Services and Activities -
Prelude Therapeutics
Professional Services and Activities -
Remix Therapeutics
Professional Services and Activities (Uncompensated) -
Rgenta Therapeutics Inc.
Equity; Professional Services and Activities -
University of Pittsburgh
Professional Services and Activities
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures